Sun Pharmaceutical Industries Revenues And Stock Struggling Again Under Site Boycott Despite Their Agreement To Buy Fellow Pharma Company Organon

July 15. 2026

Richard Ascroft (CEO of Sun Pharmaceutical Industries in America)

Sun Pharmaceutical Industries shares and revenues continue to slide under the boycott I called for due to their damaging products, such as the deadly antibiotic Bactrim, which has killed over 300 people in America, and sickened thousands. Bactrim, which goes under the brand name Septra in the United Kingdom, also killed people in Britain, and sickened thousands there as well. It was pulled from the approved medicines list and Parliamentary hearings were held on the dangerous pharma drug.

My mom is one of the people who was sickened by Bactrim in America. Sun Pharmaceutical Industries contacted me and apologized (after an ongoing lawsuit was filed against them regarding my mom). However, Sun Pharmaceutical Industries refuse to make amends by reimbursing the money I've lost in extra costs regarding taking care of my mom (over $20,000) or pay for any of her future care. My mom is 84. She was prescribed Bactrim on August 31, 2023 by Cano Health. I wrote about it then Cano Health started going under (Cano Health Closes Locations After Filing For Bankruptcy).

I'd never seen my mom get so sick and so fast until Bactrim. It was very alarming and traumatic. I've seen firsthand how damaging Bactrim is and how rapidly it causes extensive damage, and advise you not to use it. If you need an antibiotic, ask your doctor not to give you Bactrim, but another one instead. Amoxicillin, Augmentin, and Cefepime are effective antibiotics. I've not been paid or compensated to state that; it's just what I've observed regarding others who were prescribed those antibiotics and recovered.

There is something in Bactrim's formula that attacks the lungs in a number of people, especially children (Sun Pharmaceutical Industries Antibiotic Drug Bactrim Gave Young Girl Lung Failure That Left Her Fighting For Her Life And Others Who Took It Needing Lung Transplants).

A number of previously healthy people, including children, who died due to Bactrim suffered horrendous lung damage. Sun Pharmaceutical Industries needs to change the formula and clean up their factories. When I broached the subject in an email, they didn't take it too well. In future hearings they are going to wish they had taken my advice and fixed Bactrim's formula.

However, one thing I've alarmingly learned regarding Sun Pharmaceutical Industries is they put profits ahead of people. They are okay with Bactrim killing off hundreds and sickening many thousands, as long as it makes them money. That's a horrible business model and it is going to catch up with them. Currently, they lost a class action lawsuit and have been forced to pay $200 million for overcharging consumers for generic drugs. The mere fact generic drugs are meant to be cheaper alternatives and  Sun Pharmaceutical Industries overcharged for them anyway, speaks volumes about their lack of ethics.

Dilip Shanghvi (founder and Managing Director of Sun Pharmaceutical Industries in India)

Sun Pharmaceutical Industries, based in India, has a long history of factory violations that caused nations such as America and China to cite the company and issue suspensions and recalls of several of their products (Sun Pharmaceutical Industries Factory Suspended By The Chinese Government After Failing Several U.S. Government Safety Inspections Confirming Previous Site Claims Their Drugs Are Dangerous And Deadly).

It's alarming that they keep failing factory inspections in multiple nations. This is not something that is unfixable. There are many business methods and processes to ensure clean factories, safe products and the highest working order. It It is clear, this particular company, Sun Pharmaceutical Industries, does not want to pay to maintain a proper standard. That makes them a danger to sick people everywhere who end up being prescribed their products.

Case in point, Sun Pharmaceutical Industries most recent recall is for glass particles in their cancer drug (Another Sun Pharmaceutical Industries Drug Being Recalled Due To Being Dangerous And Contaminated). That is horrendously dangerous. The glass particles could cause bloodclots that kill the patient. What kind of negligent madness is that.

Sun Pharmaceutical Industries is attempting to buy U.S. based Organon (which was originally founded in the Netherlands) due to Sun Pharma's falling revenues. There is an agreement in place. Both companies have U.S. headquarters in New Jersey. However, I'm of the belief that due to their murky history Sun Pharmaceutical Industries will just drag Organon down with them. They are both in danger of financial collapse.

STORY SOURCE

Sun Pharmaceutical Industries slides Friday, underperforms market

July 10, 2026, 6:32 a.m. ET - Sun Pharmaceutical Industries Ltd. 524715 +0.84% shares inched down 0.19% to 1,935.25 Indian rupees Friday, on what proved to be an all-around positive trading session for the stock market, with the BSE SENSEX Index 1 -0.72% rising 1.08% to 77,569.39. Sun Pharmaceutical Industries Ltd. closed 0.86% short of its 52-week high of 1,952.10 rupees, which the company achieved on July 9th.

https://www.marketwatch.com

Sun Pharmaceutical Industries falls Tuesday, underperforms competitors

July 7, 2026, 6:32 a.m. ET - Shares of Sun Pharmaceutical Industries Ltd. 524715 +0.84% inched down 0.53% to 1,903.00 Indian rupees Tuesday, on what proved to be an all-around rough trading session for the stock market, with the BSE SENSEX Index 1 -0.72% falling 0.13% to 78,180.72. Sun Pharmaceutical Industries Ltd. closed 1.14% short of its 52-week high of 1,925.00 rupees, which the company reached on July 3rd.

https://www.marketwatch.com

Sun Pharmaceutical and Taro $200M Generic Drug Settlement

Consumers who purchased or paid for certain generic drugs between 2009 and 2019 may be eligible to claim a share of a $200,000,000 class action settlement. Sun Pharmaceutical and Taro $200M Generic Drug Settlement Sun Pharmaceutical and Taro $200M Generic Drug Settlement Danielle Toth Danielle Toth Editor Published July 13, 2026 1:32 PM Updated July 14, 2026 Join the Discussion Consumers who purchased, paid for or provided reimbursement for certain generic prescription drugs between May 1, 2009, and Dec. 31, 2019, may be eligible to claim a cash payment from a class action settlement.

Sun Pharmaceutical Industries Inc. and Taro Pharmaceuticals USA Inc. agreed to pay $200 million to settle a class action lawsuit. The lawsuit alleged they violated federal and state antitrust laws, consumer protection statutes and common law by engaging in conduct that harmed competition and caused end payers to overpay for certain generic drugs..

https://www.claimdepot.com

RELATED ARTICLES

Sun Pharmaceutical Industries Factory Suspended By The Chinese Government After Failing Several U.S. Government Safety Inspections Confirming Previous Site Claims Their Drugs Are Dangerous And Deadly

Sun Pharmaceutical Industries Antibiotic Drug Bactrim Gave Young Girl Lung Failure That Left Her Fighting For Her Life And Others Who Took It Needing Lung Transplants

Sun Pharmaceutical Industries Is Not Doing What Is In The Best Interest Of Their Shareholders Which Will Lead To Financial And Legal Trouble

Sun Pharmaceutical Industries Has A History Of Safety Violations At Their Plants That Produced The Deadly Antibiotic Bactrim